Table of Contents

company-logo

Tenaya Therapeutics, Inc., a biotechnology company, discovers, develops, and delivers therapies for heart disease in the United States. It develops its products through cellular regeneration, gene therapy, and precision medicine platforms. The company is developing TN-201, an adeno-associated virus (AAV)-based gene therapy to address genetic hypertrophic cardiomyopathy (gHCM) caused by haploinsufficient myosin binding protein C3 (MYBPC3) gene mutations; and TN-301, a small molecule inhibitor of histone deacetylase 6 (HDAC6i) for use in heart failure with preserved ejection fraction (HFpEF) and genetic dilated cardiomyopathy (gDCM). It is also developing TN-401, an AAV-based gene therapy that addresses genetic arrhythmogenic right ventricular cardiomyopathy (gARVC) caused by plakophilin 2 (PKP2) gene mutations; an AAV-based gene therapy designed to deliver the dwarf open reading frame (DWORF) gene in the heart for DCM; and Reprogramming program, an AAV-based approach for cardiac regeneration to replace heart cells lost in patients experiencing heart failure due to prior myocardial infarction. The company was incorporated in 2016 and is headquartered in South San Francisco, California.

Tenaya Therapeutics Dividend Announcement

• Tenaya Therapeutics does not currently offer dividends, we're keeping a close eye on its growth potential and financial developments.
• Stay tuned for updates on Tenaya Therapeutics dividend policy and future announcements. In the meantime, explore other dividend-yielding opportunities on our website.

Tenaya Therapeutics Dividend History

Tenaya Therapeutics Dividend Yield

Tenaya Therapeutics current trailing twelve-month (TTM) dividend yield is -%. Interested in purchasing Tenaya Therapeutics stock? Use our calculator to estimate your expected dividend yield:

Tenaya Therapeutics Financial Ratios

P/E ratio-2.18
PEG ratio0.38
P/B ratio2.26
ROE-86.16%
Payout ratio0.00%
Current ratio5.27
Quick ratio5.27
Cash Ratio0.51

Tenaya Therapeutics Dividend FAQ

Does Tenaya Therapeutics stock pay dividends?
Tenaya Therapeutics does not currently pay dividends to its shareholders.
Has Tenaya Therapeutics ever paid a dividend?
No, Tenaya Therapeutics has no a history of paying dividends to its shareholders. Tenaya Therapeutics is not known for its dividend payments.
Why doesn't Tenaya Therapeutics pay dividends?
There are several potential reasons why Tenaya Therapeutics would choose not to pay dividends to their shareholders:

1. Growth opportunities: Companies, especially in fast-growing industries like technology, reinvest earnings into expansion, R&D, or acquisitions to fuel future growth and increase company value.

2. Tax implications: Not paying dividends can reduce the tax burden on shareholders, who may prefer to defer taxes until selling shares and realizing capital gains.

3. Investor preferences: Some investors prefer companies to reinvest profits for higher long-term returns, particularly those seeking capital appreciation over income.

4. Capital allocation priorities: Companies may allocate cash to pay down debt, fund share buybacks, or invest in projects with higher returns than dividends.

5. Market expectations: In certain sectors, like technology, reinvesting profits for growth and innovation is often prioritized over distributing dividends to shareholders.
Will Tenaya Therapeutics ever pay a dividend?
The decision for a company to pay dividends depends on various factors including its financial performance, growth prospects, capital allocation priorities, and shareholder preferences. While Tenaya Therapeutics has not paid dividends historically and has instead focused on reinvesting its earnings for growth, it's ultimately up to the company's management and board of directors to decide whether to initiate a dividend policy in the future.
Is Tenaya Therapeutics a dividend aristocrat?
Tenaya Therapeutics is not considered a Dividend Aristocrat. The term "Dividend Aristocrat" is typically used to describe a company in the S&P 500 index that has increased its dividend payouts for at least 25 consecutive years.
Is Tenaya Therapeutics a dividend king?
Tenaya Therapeutics is not classified as a "Dividend King". A Dividend King is a company that has managed to increase its dividend payouts for 50 consecutive years or more, which is an even more selective group than the Dividend Aristocrats.
Is Tenaya Therapeutics a dividend stock?
No, Tenaya Therapeutics is not considered a dividend stock. A dividend stock is a stock of a company that regularly pays out dividends to its shareholders.
How to buy Tenaya Therapeutics stocks?
To buy Tenaya Therapeutics you need a brokerage account. Open an account with a reputable brokerage firm that offers access to the stock market. Consider factors such as fees and account minimums.

Place an order: Use the brokerage's trading platform to place an order to buy Tenaya Therapeutics stock.

Remember that buying stocks involves risk, and it's important to carefully consider your investment goals, risk tolerance, and conduct thorough research before making any investment decisions.